Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
4.180
+0.130 (3.21%)
At close: Apr 3, 2025, 4:00 PM
4.300
+0.120 (2.87%)
After-hours: Apr 3, 2025, 7:49 PM EDT
Dogwood Therapeutics Employees
Dogwood Therapeutics had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,215,957
Market Cap
7.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4 | 0 | - |
Dec 31, 2022 | 4 | -1 | -20.00% |
Dec 31, 2021 | 5 | 2 | 66.67% |
Dec 31, 2020 | 3 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DWTX News
- 19 hours ago - Dogwood Therapeutics, Inc. Regains Nasdaq Compliance - GlobeNewsWire
- 3 days ago - Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 16 days ago - Dogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic Pain - GlobeNewsWire
- 21 days ago - Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 6 months ago - Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) - GlobeNewsWire
- 8 months ago - Virios Therapeutics Announces Second Quarter 2024 Financial Results - GlobeNewsWire
- 8 months ago - Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - GlobeNewsWire
- 9 months ago - Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center - GlobeNewsWire